BETA

Open Payments

SPENCER MELBY

Type
Physician · Allopathic & Osteopathic Physicians / Thoracic Surgery (Cardiothoracic Vascular Surgery)
Where
OREM, UT
NPI
1720081243
Received
$29,644 in 49 records, 2019 to 2025
As principal investigator
$402,633 of research payments to others in 62 records
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2025General payment5$250
2024General payment10$274
2023General payment8$204
2022General payment3$4,955
2021General payment3$288
2020General payment6$15,410
2019General payment14$8,259

By company

CompanyRecordsAmountYears
ClearFlow Inc.4$25,8852019–2022
LivaNova USA, Inc.2$1,3482019
Edwards Lifesciences Corporation8$7552019–2022
Artivion, Inc.7$4482019–2023
Medtronic Vascular, Inc.2$2332019–2020
AtriCure, Inc.4$2002020–2025
DePuy Synthes Sales Inc.2$1612024–2025
Bolton Medical Inc1$1122025
Getinge USA Sales, LLC2$872023–2024
Veran Medical Technologies, Inc.1$852019
Novartis Pharmaceuticals Corporation3$592023–2024
Zimmer Biomet Holdings, Inc.1$432023
Merck Sharp & Dohme LLC2$322023–2025
Actelion Pharmaceuticals US, Inc.1$292023
Janssen Pharmaceuticals, Inc1$282024
Arthrex, Inc.2$282024
Lexicon Pharmaceuticals, Inc.1$242023
PFIZER INC.1$192024
Amryt Pharma Holdings Ltd1$182023
Boston Scientific Corporation1$152024
Ethicon US, LLC1$152024
Quest Medical Inc.1$92020

By nature of payment

NatureRecordsAmount
Honoraria1$15,000
Consulting Fee1$6,000
Compensation for services other than consulting, including serving as faculty or as a speaker at a v2$5,951
Food and Beverage43$2,664
Travel and Lodging2$28

Records

DateCompanyAmountNatureFormProductStudyYear
2025-10-24AtriCure, Inc.$19Food and BeverageIn-kind items and servicesATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM Device, CARDIOVASCULAR2025
2025-10-17Bolton Medical Inc$112Food and BeverageIn-kind items and servicesTHORAFLEX HYBRID Device, ENDOVASCULAR AORTIC REPAIR2025
2025-04-21AtriCure, Inc.$19Food and BeverageIn-kind items and servicesSYNERGY ABLATION SYSTEM Device, CARDIOVASCULAR2025
2025-02-04DePuy Synthes Sales Inc.$81Food and BeverageIn-kind items and servicesMATRIXRIB Device, CMF-Trauma2025
2025-01-16Merck Sharp & Dohme LLC$17Food and BeverageIn-kind items and servicesVERQUVO Drug, CARDIOVASCULAR2025
2024-12-10Novartis Pharmaceuticals Corporation$21Food and BeverageIn-kind items and servicesENTRESTO Drug, Cardiology/Vascular Diseases2024
2024-10-29Ethicon US, LLC$15Food and BeverageIn-kind items and servicesVISTASEAL Biological, Biosurgical2024
2024-10-01DePuy Synthes Sales Inc.$79Food and BeverageIn-kind items and servicesMATRIXRIB Device, CMF-Trauma2024
2024-09-19Arthrex, Inc.$14Travel and LodgingIn-kind items and services2024
2024-09-19Arthrex, Inc.$14Travel and LodgingIn-kind items and services2024
2024-07-31PFIZER INC.$19Food and BeverageIn-kind items and servicesVYNDAQEL Drug, CARDIOVASCULAR2024
2024-04-15Novartis Pharmaceuticals Corporation$20Food and BeverageIn-kind items and servicesLEQVIO Drug, Cardiology/Vascular Diseases2024
2024-04-09Getinge USA Sales, LLC$44Food and BeverageIn-kind items and servicesVasoview Hemopro 2 Device, Cardiology/Vascular Diseases2024
2024-02-01Janssen Pharmaceuticals, Inc$28Food and BeverageIn-kind items and servicesXARELTO Drug, Cardiovascular & Metabolism2024
2024-01-24Boston Scientific Corporation$15Food and BeverageIn-kind items and servicesWATCHMAN FLX Device, WATCHMAN FLX_IC2024
2023-11-30Lexicon Pharmaceuticals, Inc.$24Food and BeverageIn-kind items and servicesInpefa Drug, Inhibitor of SGLT2 and SGLT12023
2023-11-14Actelion Pharmaceuticals US, Inc.$29Food and BeverageIn-kind items and servicesUPTRAVI Drug, Cardiology2023
2023-11-10Getinge USA Sales, LLC$42Food and BeverageIn-kind items and servicesVasoview Hemopro 2 Device, Cardiology/Vascular Diseases2023
2023-09-28Zimmer Biomet Holdings, Inc.$43Food and BeverageIn-kind items and servicesSTERNALOCK BLU SYSTEM Device, CMF & Thoracic2023
2023-09-20Amryt Pharma Holdings Ltd$18Food and BeverageIn-kind items and servicesJuxtapid Drug, Cardiology/Vascular Diseases2023
2023-04-27Artivion, Inc.$14Food and BeverageIn-kind items and servicesBIOGLUE SURGICAL ADHESIVE Device, Surgical Adhesive2023
2023-04-13Novartis Pharmaceuticals Corporation$17Food and BeverageIn-kind items and servicesLEQVIO Drug, Cardiology/Vascular Diseases2023
2023-02-06Merck Sharp & Dohme LLC$14Food and BeverageIn-kind items and servicesVERQUVO Drug, CARDIOVASCULAR2023
2022-12-14Edwards Lifesciences Corporation$21Food and BeverageIn-kind items and servicesINSPIRIS RESILIA AORTIC VALVE Device, Pericardial Heart Valves2022
2022-11-08ClearFlow Inc.$4,751Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentPleuraflow System with FlowGlide Device, Cardiovascular2022
2022-06-16Edwards Lifesciences Corporation$182Food and BeverageIn-kind items and servicesEdwards SAPIEN 3 Ultra Transcatheter Heart Valve Device, Transcatheter Heart Valves2022
2021-11-18Edwards Lifesciences Corporation$136Food and BeverageIn-kind items and servicesEdwards SAPIEN 3 Ultra Transcatheter Heart Valve Device, Transcatheter Heart Valves2021
2021-05-20Edwards Lifesciences Corporation$124Food and BeverageIn-kind items and servicesEdwards SAPIEN 3 Ultra Transcatheter Heart Valve Device, Transcatheter Heart Valves2021
2021-01-26Edwards Lifesciences Corporation$26Food and BeverageIn-kind items and services2021
2020-06-24ClearFlow Inc.$134Food and BeverageIn-kind items and servicesPleuraFlow Device, Cardiovascular2020
2020-02-19Quest Medical Inc.$9Food and BeverageCash or cash equivalentMyocardial Protection System Device, Cardiology2020
2020-02-13AtriCure, Inc.$80Food and BeverageCash or cash equivalentATRICURE ATRICLIP LAA EXCLUSION Device, CARDIOVASCULAR2020
2020-02-06ClearFlow Inc.$15,000Honoraria (6 payments)Cash or cash equivalentPleuraflow Device, Cardiovascular2020
2020-01-26Medtronic Vascular, Inc.$104Food and BeverageIn-kind items and servicesCardioblate Device, Ablation2020
2020-01-14AtriCure, Inc.$81Food and BeverageCash or cash equivalentATRICURE ATRICLIP LAA EXCLUSION Device, CARDIOVASCULAR2020
2019-12-19Artivion, Inc.$10Food and BeverageIn-kind items and servicesBioGlue Device, Cardiology and Vascular Diseases2019
2019-12-11Edwards Lifesciences Corporation$27Food and BeverageIn-kind items and servicesINSPIRIS RESILIA aortic valve Device, Pericardial Heart Valves2019
2019-12-10Artivion, Inc.$54Food and BeverageIn-kind items and servicesBioGlue Device, Cardiology and Vascular Diseases2019
2019-10-17Edwards Lifesciences Corporation$121Food and BeverageIn-kind items and servicesINSPIRIS RESILIA aortic valve Device, Pericardial Heart Valves2019
2019-06-25Artivion, Inc.$75Food and Beverage (2 payments)In-kind items and servicesBioGlue Device, Cardiology and Vascular Diseases2019
2019-06-18Edwards Lifesciences Corporation$114Food and BeverageIn-kind items and services2019
2019-06-07ClearFlow Inc.$6,000Consulting FeeCash or cash equivalentPleuraFlow Device, Cardiovascular2019
2019-05-16LivaNova USA, Inc.$1,200Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentPerceval Device, Cardiology/Vascular Diseases2019
2019-05-04Artivion, Inc.$147Food and BeverageIn-kind items and servicesBioGlue Device, Cardiology and Vascular Diseases2019
2019-05-01LivaNova USA, Inc.$148Food and BeverageIn-kind items and servicesPerceval Device, Cardiology/Vascular Diseases2019
2019-04-04Artivion, Inc.$10Food and BeverageIn-kind items and servicesBioGlue Device, Cardiology and Vascular Diseases2019
2019-01-28Artivion, Inc.$135Food and BeverageIn-kind items and servicesBioGlue Device, Cardiology and Vascular Diseases2019
2019-01-28Veran Medical Technologies, Inc.$85Food and BeverageCash or cash equivalentSpin Device, Pulmonology2019
2019-01-27Medtronic Vascular, Inc.$129Food and BeverageIn-kind items and servicesSimulus Device, Heart Valves2019

Research payments naming this person as principal investigator

DateCompanyPaid toAmountStudyYear
2023-12-31ABBVIE INC.WA UNIVERSITY SCHOOL OF MEDICINE$4,500Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Patients Undergoing Open2023
2023-02-02Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$3,400Beating heart mitral valve repair with the HARPOON System (RESTORE)2023
2022-12-31ABBVIE INC.WASHINGTON UNIVERSITY SCHOOL OF MED$1,800Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Patients Undergoing Open2022
2022-12-29ABBVIE INC.WASHINGTON UNIVERSITY SCHOOL OF MED$2,191Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Patients Undergoing Open2022
2022-11-03ABBVIE INC.WASHINGTON UNIVERSITY SCHOOL OF MED$2,516Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Patients Undergoing Open2022
2022-10-11ABBVIE INC.WASHINGTON UNIVERSITY SCHOOL OF MED$2,235Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Patients Undergoing Open2022
2022-10-03ABBVIE INC.WASHINGTON UNIVERSITY SCHOOL OF MED$4,760Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Patients Undergoing Open2022
2022-08-02Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$4,555Beating heart mitral valve repair with the HARPOON System (RESTORE)2022
2022-07-05Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$2,040Beating heart mitral valve repair with the HARPOON System (RESTORE)2022
2022-06-13Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$7,176Commence Study 2012-022022
2022-06-07Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$2,040Beating heart mitral valve repair with the HARPOON System (RESTORE)2022
2022-03-15Allergan, Inc.WASHINGTON UNIVERSITY$168A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2022
2022-03-09Allergan, Inc.WASHINGTON UNIVERSITY$1,295A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2022
2021-12-31Allergan, Inc.WASHINGTON COUNTY MEMORIAL HOSPITAL HOME$255A MULTI-CENTERED, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY O2021
2021-12-31Allergan, Inc.WASHINGTON COUNTY MEMORIAL HOSPITAL HOME$34,005A MULTI-CENTERED, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY O2021
2021-11-04Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$1,564Commence Study 2012-022021
2021-10-21Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$2,040Beating heart mitral valve repair with the HARPOON System (RESTORE)2021
2021-10-04Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$4,215Beating heart mitral valve repair with the HARPOON System (RESTORE)2021
2021-07-13Allergan, Inc.WASHINGTON UNIVERSITY$13,817A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2021
2021-07-06Allergan, Inc.WASHINGTON UNIVERSITY$8,425A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2021
2021-07-06Allergan, Inc.WASHINGTON UNIVERSITY$740A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2021
2021-07-06Allergan, Inc.WASHINGTON UNIVERSITY$2,720A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2021
2021-06-28Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$1,012Beating heart mitral valve repair with the HARPOON System (RESTORE)2021
2021-06-24Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$5,100Commence Study 2012-022021
2021-05-24Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$2,222Commence Study 2012-022021
2021-05-13Allergan, Inc.WASHINGTON UNIVERSITY$1,724A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2021
2021-04-22Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$1,020Commence Study 2012-022021
2021-04-22Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$2,040Beating heart mitral valve repair with the HARPOON System (RESTORE)2021
2021-04-13Allergan, Inc.WASHINGTON UNIVERSITY$2,767A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2021
2021-03-17Allergan, Inc.WASHINGTON UNIVERSITY$12,137A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2021
2021-02-25Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$13,090Beating heart mitral valve repair with the HARPOON System (RESTORE)2021
2021-02-18Allergan, Inc.WASHINGTON UNIVERSITY$3,281A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2021
2020-12-31Allergan, Inc.WASHINGTON UNIVERSITY$50,264A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2020
2020-12-15Allergan, Inc.WASHINGTON UNIVERSITY$5,645A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2020
2020-11-05Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$420Commence Study 2012-022020
2020-11-02Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$5,464Commence Study 2012-022020
2020-10-15Allergan, Inc.WASHINGTON UNIVERSITY$2,720A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2020
2020-10-01Allergan, Inc.WASHINGTON UNIVERSITY$2,720A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2020
2020-08-20Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$1,360Commence Study 2012-022020
2020-07-22Allergan, Inc.WASHINGTON UNIVERSITY$1,020A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2020
2020-07-22Allergan, Inc.WASHINGTON UNIVERSITY$2,380A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2020
2020-07-22Allergan, Inc.WASHINGTON UNIVERSITY$1,360A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2020
2020-05-12Allergan, Inc.WASHINGTON UNIVERSITY$15,028A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2020
2020-04-23Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$1,020Commence Study 2012-022020
2020-02-21Allergan, Inc.WASHINGTON UNIVERSITY$2,516A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2020
2020-02-13Allergan, Inc.WASHINGTON UNIVERSITY$3,281A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2020
2019-12-31Allergan, Inc.WASHINGTON UNIVERSITY$49,901A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2019
2019-12-11Allergan, Inc.WASHINGTON UNIVERSITY$2,516A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o2019
2019-07-31Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$340Commence Study 2012-022019
2019-07-17Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$3,861Commence Study 2012-022019
2019-07-10Quest Medical Inc.Barnes-Jewish Hospital$41,637Microplegia Study2019
2019-05-24Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$1,020Commence Study 2012-022019
2019-05-07Allergan, Inc.Washington University School Of Medicine$6,800A MULTI-CENTERED, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY O2019
2019-05-07Allergan, Inc.Washington University School Of Medicine$2,040A MULTI-CENTERED, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY O2019
2019-05-07Allergan, Inc.Washington University School Of Medicine$3,740A MULTI-CENTERED, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY O2019
2019-05-07Allergan, Inc.Washington University School Of Medicine$2,638A MULTI-CENTERED, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY O2019
2019-05-07Allergan, Inc.Washington University School Of Medicine$1,360A MULTI-CENTERED, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY O2019
2019-04-26Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$1,857Commence Study 2012-022019
2019-04-24Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$680Commence Study 2012-022019
2019-03-27Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$14,280Commence Study 2012-022019
2019-03-27Edwards Lifesciences CorporationWASHINGTON UNIVERSITY$11,329Commence Study 2012-022019
2019-02-22LivaNova USA, Inc.WASHINGTON UNIVERSITY$12,580Persist-AVR Study2019

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Utah CountyOrem city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Orem, UT, county Utah County, UT, state Utah; placed by its city name.

MeasurePlace (city or town)
Orem, UT		County
Utah County, UT		State
Utah
Population B0100397,182705,4003,392,331
Population, 2020 census P198,129659,3993,271,616
Median age B0100227.025.832.0
Under 18 B0100126.3%31.6%27.8%
65 and over B0100110.4%7.9%11.9%
Households B1100131,291203,0181,124,822
Foreign born B0500212.2%8.2%8.9%
Median household income B19013$83,342$100,671$95,166
Median family income B19113$92,847$110,986$109,675
Per capita income B19301$35,876$37,082$40,873
Poverty rate B1700110.2%8.7%8.5%
Unemployment rate B230253.9%3.8%3.6%
Civilian labor force B2302553,561363,7711,778,106
Mean commute (minutes) B0801320.122.622.1
Bachelor's degree or higher B1500343.6%44.4%37.7%
Housing units B2500132,835211,0661,223,468
Owner-occupied B2500357.8%68.3%70.2%
Renters B2500342.2%31.7%29.8%
Median home value B25077$472,300$538,700$489,400
Median gross rent B25064$1,438$1,541$1,496
White, not Hispanic B0300271.7%77.6%74.7%
Black B030020.7%0.7%1.1%
Hispanic or Latino B0300219.4%14.5%15.9%
Asian B030022.0%1.5%2.4%
American Indian and Alaska Native B030020.4%0.2%0.6%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Orem, UT.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.